tm logo

Monitor this mark

View On USPTO

SARCLISA SIMTRA
Dead/Abandoned
ABANDONED – EXPRESS AFTER PUB

on 27 Aug 2024

Last Applicant/ Owned by

Sanofi

46 avenue de la Grande Armée

Paris

FR

75017

Serial Number

98310512 filed on 12th Dec 2023

Registration Number

N/A

Correspondent Address

Karen Lim

KAREN LIM FROSS ZELNICK LEHRMAN & ZISSU, P.C.

NEW YORK, NY 10036

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SARCLISA SIMTRA

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98310512

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SYN 2313984

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Aug 2024ABANDONMENT - AFTER PUBLICATION
27th Aug 2024ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
26th Aug 2024TEAS EXPRESS ABANDONMENT RECEIVED
20th Aug 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Aug 2024PUBLISHED FOR OPPOSITION
31st Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Jul 2024APPROVED FOR PUB - PRINCIPAL REGISTER
11th Jul 2024ASSIGNED TO EXAMINER
26th Jun 2024ASSIGNED TO LIE
26th Jun 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED